Dr. Smith with Your Health

BIBLIOGRAPHY

(1)Barnes DM. Nervous and immune system disorders linked in a variety of diseases. Science 1986; 232:160-1.
(2)Plata-Salaman CR. Immunomodulators and feeding regulation: a humoral link between the immune and nervous systems. Brain, Behavior, and Immunity 1989; 3:193-213.
(3)Hirsch JD, Mullen CA, Beer B. Modulation of murine interleukin production and cellular immunoreactivity by the autonomic nervous system. In: Kluger MJ, Oppenheim JJ, Powanda MC, eds. The physiologic, metabolic and immunological actions of interleukin-1. New York: Alan R. Liss, Inc. 1985; 151-60. (Progress in leukocyte biology; vol 2).
(4)Kudlacz EM, Knippenberg RW. In vitro and in vivo effects of tachykinins on immune cell function in guinea pig airways. J. Neuroimmunology 1984; 50:119-25.
(5)Payan DG, Brewster DR, Goetzl EJ. Specific stimulation of human T lymphocytes by substance P. J. Immunol. 1983; 131:1613-15.
(6)Calvo C, Calvo F, Chavanel G, Senik A. Substance P enhances Il-2 expression in activated human T cells. J. Immunol. 1992; 148:3498-3504.
(7)Rameshwar P, Gascon P, Ganea D. Immunoregulatory effects of neuropeptides. Stimulation of interleukin-2 production by substance P. J. Neuroimmunol. 1992; 37:65-74.
(8)Jancso N, Jancso-Gabor A, Szolcsanyi J. Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br. J. Pharmacol. Chemother. 1967; 31:138-51.
(9)Dernow B. Role of tachykinins in neurogenic inflammation. J. Immunol. 1985; 135(suppl):812-5.
(10)Levine JD, Moskowitz MA, Basbaum AI. The contribution of neurogenic inflammation in experimental arthritis. J. Immunol. 1985; 135(suppl):843-7.
(11)Maslinski W. Cholinergic receptors of lymphocytes. Brain, Behavior and Immunity 1989; 3:1-14.
(12)Maslinski W, Grabczewska E, Laskowska-Bozek H, Ryzewski J. Expression of muscarinic cholinergic receptors during T cell maturation in the thymus. Eur. J. Immunol. 1987; 17:1059-63.
(13)Madden KS, Felten SY, Felten DL, Sundaresan PR, Livnat S. Sympathetic neural modulation of the immune system I. Depression of T cell immunity in vivo and in vitro following chemical sympathectomy. Brain Behav. Immun. 1989; 3:72-89.
(14)Wang T, Sheppard JR, Foker JE. Rise and fall of cyclic AMP required for onset of lymphocyte DNA synthesis. Science 1978; 201:155-7.
(15)Felten DL, Felten SY, Carlson SL, Olschowka JA, Livnat S. Noradrenergic and peptidergic innervation of lymphoid tissue. J. Immunol. 1985; 135(suppl):755-65.
(16)Bellinger DL, Lorton D, Romano TA, Olschowka JA, Felten SY, Felten DL. Neuropeptide innervation of lymphoid organs. Ann. N.Y. Acad. Sci. 1990; 594:17-33.
(17)Lorton D, Bellinger DL, Felten SY, Felten DL. Substance P innervation of spleen in rats: nerve fibers associate with lymphocytes and macrophages in specific compartments of the spleen. Brain Behav. Immun. 1991; 5:29-40.
(18)Romano TA, Felten SY, Felten DL, Olschowka JA. Neuropeptide-Y innervation of the rat spleen: another potential immunomodulatory neuropeptide. Brain Behav. Immun. 1991; 5:116-31.
(19)Madden KS, Felten SY, Felten DL, Hardy CA, Livnat S. Sympathetic neural modulation of the immune system II. Induction of lymphocyte proliferation and migration in vivo by chemical sympathectomy. J. Neuroimmunology 1994; 49:67-75.
(20)Madden KS, Moynihan JA, Brenner GJ, Felten SY, Felten DL, Livnat S. Sympathetic neural modulation of the immune system III. Alterations in T and B cell proliferation and differentiation in vitro following chemical sympathectomy. J. Neuroimmunology 1994; 49:77-87.
(21)Miles K, Quintans J, Chelmicka-Schorr E, Arnason BGW. The sympathetic nervous system modulates antibody response to thymus-independent antigens. J. Neuroimmunology 1981; 1:101-5.
(22)Kidron D, Saphier D, Ovadia H, Weidenfeld J, Abramsky O. Central administration of immunomodulatory factors alters neural activity and adrenocortical secretion. Brain Behav. Immun. 1989; 3:15-27.
(23)Beal MC. Viscerosomatic reflexes: a review. J. Am. Osteopath. Assoc. 1985; 85:786-801.
(24)Sato A, Schmidt RF. Somatosympathetic reflexes: afferent fibers, central pathways, discharge characteristics. Physiological Reviews 1973; 4:916-47.
(25)Van Buskirk RL. Nociceptive reflexes and the somatic dysfunction: a model. J. Am. Osteopath. Assoc. 1990; 90:792-809.
(26)Jarmel ME. Possible role of spinal joint dysfunction in the genesis of sudden cardiac death. J. Man. Phys. Ther. 1989; 6:469-76.
(27)Falk JW. Bowel and bladder dysfunction secondary to lumbar dysfunctional syndrome. Chiropractic Technique 1990; 2:45-8.
(28)Beal MC, Morlock JW. Somatic dysfunction associated with pulmonary disease. J. Am. Osteopath. Assoc. 1984; 84:179-83.
(29)Beal MC, Kleiber GE. Somatic dysfunction as a predictor of coronary artery disease. J. Am. Osteopath. Assoc. 1985; 85:302-7.
(30)Pikalov AI, Kharin VV. Use of spinal manipulative therapy in the treatment of duodenal ulcer: a pilot study. J. Man. Phys. Ther. 1994; 17:310-3.
(31)Korr IM. The spinal cord as organizer of disease processes: some preliminary perspectives. J. Am. Osteopath. Assoc. 1976; 76:35-45.
(32)Korr IM. The spinal cord as organizer of disease processes: II. The peripheral autonomic nervous system. J. Am. Osteopath. Assoc. 1979; 79:82-90.
(33)Korr IM. The spinal cord as organizer of disease processes: III. Hyperactivity of sympathetic innervation as a common factor in disease. J. Am. Osteopath. Assoc. 1979; 79:232-7.
(34)Fidelibus JC. An overview of neuroimmunomodulation and a possible correlation with musculoskeletal system function. J. Man. Phys. Ther. 1989; 4:289-92.
(35)Vora GS, Bates HA. The effects of spinal manipulation on the immune system (a preliminary report). ACA Journal of Chiropractic 1980; 14(suppl):103-5.
(36)Brennan PC, Kokjohn K, Kaltinger CJ. Enhanced phagocytic cell respiratory burst induced by spinal manipulation: potential role of substance P. J. Man. Phys. Ther. 1991; 7:399-407.
(37)Selano JL, Hightower BC, Pfleger B, Collins KF, Grostic JD. The effects of specific upper cervical adjustments on the CD4 counts of HIV positive patients. Chiropractic Research Journal 1994; 1:32-9.

Back to HIV and CHIROPRACTIC

Dr. Brian A. Smith is a chiropractic doctor and naturopathic physicianwho has specialized in the treatment of immune-suppressed individuals since 1987. He is a scientific advisory board member of AIDS ReSEARCH Alliance.

He maintains a private practice in Los Angeles and can be reached at (323) 306-4909. Questions from readers are welcome as are suggestions for future articles. You can also contact him via E-mail at: Send e-mail to Dr. Smith

Back to the Article List

Articles by Dr. Brian A. Smith:

HIV and CHIRO † VITAMIN C † BETA-CAROTENE † MINERALS † DMG † PROTEIN † DIET & HIV † MORE ON PROTEIN † NUTRITION † DHEA † LIVER † CHIRO † NAC † SILVER † ALT THERAPIES †